GE HealthCare Technologies reported Q1 2026 revenue of $5.1B (+7.4% YoY), beat analyst consensus of $5.0B by $88.7M. Diluted EPS came in at $0.99 (-2.0% YoY), missed the $1.07 consensus by $0.08. GE HealthCare Technologies reports across 4 business segments, led by Imaging, Advanced Visualization Solutions (AVS), and Patient Care Solutions (PCS).
Trailing eight quarters through Q1 2026
Common questions about GE HealthCare Technologies's Q1 2026 earnings report.
GE HealthCare Technologies (GEHC) reported Q1 2026 earnings on April 29, 2026 before market open.
GE HealthCare Technologies reported revenue of $5.1B and diluted EPS of $0.99 for Q1 2026.
Revenue beat the consensus estimate of $5.0B by $88.7M. EPS missed the consensus estimate of $1.07 by $0.08.
Compared to the same quarter a year prior, revenue grew 7.4% from $4.8B a year earlier and diluted EPS declined 2.0% from $1.01.
You can read the 8-K earnings release (0001932393-26-000030) and the 10-Q periodic report (0001932393-26-000031) directly on SEC EDGAR. The filing index links above go to sec.gov.